What are the signs and symptoms of tramadol (opioid analgesic) overdose in an elderly patient or an individual with impaired renal function, and how can it be reversed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tramadol Overdose: Signs, Symptoms, and Reversal

Clinical Presentation of Tramadol Overdose

Tramadol overdose manifests primarily through respiratory depression, somnolence progressing to stupor or coma, skeletal muscle flaccidity, cold and clammy skin, constricted pupils, seizures, bradycardia, hypotension, and potentially cardiac arrest. 1

Neurological Effects

  • Seizures occur in approximately 8-10% of overdoses and are dose-related, with the lowest reported dose causing seizures being 500 mg 2, 3
  • Seizures are typically brief and self-limited 2
  • Central nervous system depression ranges from lethargy (30% of cases) to coma (5% of cases), with Glasgow Coma Score <9 occurring at higher doses 2, 3
  • Agitation and confusion occur in approximately 10% of cases, likely related to tramadol's monoamine uptake inhibition rather than opioid effects 2

Respiratory Effects

  • Respiratory depression occurs in a dose-dependent manner, typically at ingestions ≥800-2500 mg 2, 3
  • The median dose associated with respiratory depression is 2500 mg (IQR: 1600-3000 mg), significantly higher than in patients without respiratory depression 3

Cardiovascular Effects

  • Tachycardia occurs in approximately 13% of cases 2
  • Mild hypertension develops in approximately 45% of overdoses 3
  • Bradycardia and hypotension can occur in severe cases, potentially progressing to cardiac arrest 1
  • Serious arrhythmias beyond tachycardia are rare 2

Other Clinical Features

  • Nausea occurs in 14% of cases 2
  • Cold and clammy skin with constricted pupils (miosis) 1
  • Skeletal muscle flaccidity in severe overdoses 1

Special Considerations for Elderly and Renally Impaired Patients

Renal Impairment

  • Tramadol and its active metabolites are primarily eliminated renally (up to 30% of dose unchanged), making renal impairment a significant risk factor for toxicity 4, 5
  • Transient acute kidney injury can occur following tramadol overdose, even without rhabdomyolysis or multiorgan failure 6
  • The elimination half-life is prolonged in renal dysfunction, increasing risk of accumulation and delayed toxicity 4

Elderly Patients

  • Elderly patients are particularly vulnerable to opioid-induced over-sedation, respiratory depression, and confusion 7
  • Tramadol may reduce the seizure threshold, which is especially problematic in elderly patients with predisposing factors 7
  • Confusion is a particular problem in older patients due to tramadol's dual mechanism of action 7

Reversal and Management

Primary Management Approach

In tramadol overdose, primary attention must be given to establishing a patent airway and instituting assisted or controlled ventilation, as respiratory support is the cornerstone of management. 1

Naloxone Use: Critical Caveats

  • Naloxone will reverse some, but NOT all, symptoms of tramadol overdose, and critically, naloxone administration INCREASES the risk of seizures 1, 2
  • Naloxone successfully reversed sedation and apnea in 4 of 8 patients in one case series 2
  • One patient experienced a seizure immediately after naloxone administration 2
  • In animal studies, naloxone increased convulsions following toxic tramadol doses and did not change the lethality of overdose 1
  • Use naloxone cautiously and only when respiratory depression is life-threatening, as the seizure risk may outweigh benefits 1

Seizure Management

  • Seizures following tramadol overdose can be suppressed with barbiturates or benzodiazepines 1
  • Diazepam, lorazepam, or phenytoin have been used successfully in clinical practice 2
  • Do NOT use naloxone as first-line seizure treatment, as it increases seizure risk 1

Supportive Care Measures

  • Oxygen and vasopressors should be employed for circulatory shock and pulmonary edema 1
  • Cardiac massage or defibrillation may be required for cardiac arrest or arrhythmias 1
  • Monitor for and treat hypotension with intravenous fluids and vasopressors as needed 1

What Does NOT Work

  • Hemodialysis is not helpful in tramadol overdose, as it removes less than 7% of the administered dose in a 4-hour dialysis period 1
  • Standard urine drug screens are typically negative for opiates in tramadol overdose 2

Clinical Monitoring Timeline

  • All symptomatic effects from tramadol overdose manifest within 4 hours of ingestion 2
  • Mean hospital stay for symptomatic patients is approximately 15 hours (range: 2-96 hours) 2
  • ICU admission may be required, with mean ICU stay of 25 hours for severe cases 2
  • Renal function should be monitored for up to 6 days, as transient acute kidney injury can develop and resolve with minimal intervention 6

Key Pitfalls to Avoid

  • Do not rely solely on naloxone for reversal—it increases seizure risk and only partially reverses tramadol toxicity 1, 2
  • Do not assume serotonin toxicity is present; despite theoretical concerns, tramadol overdose does not meet Hunter Serotonin Toxicity Criteria in clinical practice 3
  • Do not discharge patients before 4 hours post-ingestion, as this is when all symptomatic effects manifest 2
  • Do not overlook the risk of respiratory depression at doses ≥800 mg, which requires close monitoring and potential ventilatory support 2, 3
  • In elderly or renally impaired patients, anticipate prolonged toxicity due to delayed elimination and consider extended observation periods 7, 4

References

Research

Prospective multicenter evaluation of tramadol exposure.

Journal of toxicology. Clinical toxicology, 1997

Research

Clinical pharmacology of tramadol.

Clinical pharmacokinetics, 2004

Research

Acute Tramadol Ingestion With Transient Acute Kidney Injury in an Adolescent Female.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.